Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 3/20 | 0.37 |
| ▸ | OGA | O60502 | 2/20 | 0.33 |
| ▸ | ASGR1 | P07306 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CD69 | Q07108 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565879 | 1.00 | PYGB (0.37) | PYGBOGAASGR1ALDH1A1CD69 | |
| SCHEMBL29728301 | 1.00 | PYGB (0.37) | PYGBOGAASGR1ALDH1A1CD69 | |
| SCHEMBL22866405 | 0.82 | PYGB (0.40) | PYGBALDH1A1 | |
| SCHEMBL3958284 | 0.81 | PYGB (0.37) | PYGBOGAASGR1ALDH1A1CD69 | |
| SCHEMBL31235437 | 0.81 | APLNR (0.31) | — | |
| SCHEMBL17988423 | 0.80 | PYGB (0.36) | PYGBOGAASGR1ALDH1A1 | |
| SCHEMBL15072484 | 0.78 | EPHX2 (0.47) | — | |
| SCHEMBL29484208 | 0.72 | PYGB (0.49) | PYGBOGA | |
| SCHEMBL15284881 | 0.72 | PYGB (0.49) | PYGBOGA | |
| SCHEMBL29406981 | 0.72 | PYGB (0.49) | PYGBOGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3003026-A2 | BIOCOMPATIBLE AND BIOABSORBABLE DERIVATIZED CHITOSAN COMPOSITIONS | Hemcon Medical Technologies, Inc. (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014152796-A2 | BIOCOMPATIBLE AND BIOABSORBABLE DERIVATIZED CHITOSAN COMPOSITIONS | HEMCON MEDICAL TECHNOLOGIES, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| EP-0914162-A2 | USE OF OLIGOSACCHARIDES FOR NEUTRALISING $i(E. COLI) TOXINS | SYNSORB Biotech Inc. (CA) | 1999-05-12 | — | — | EP | disclosed |
| WO-1997049431-A2 | USE OF OLIGOSACCHARIDES FOR NEUTRALISING E. COLI TOXINS | SYNSORB BIOTECH, INC. (CA) | 1997-12-31 | — | — | WO | disclosed |